$1.75
▼ -0.6% Today
as of Oct 2, 16:45 ET
Last 30 days
Recent Press Releases & News
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
Aptevo Reports 93% Clinical Benefit Rate for Mipletamig Triplet in TP53-Mutated AML
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
APVO earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±0.7% on average; after the most recent report on May 13, 2026 it moved -1.4%. APVO beat the consensus EPS estimate in 0 of its last 3 reported quarters. The share price of $1.75 sits near its 52-week low.
Overview
52-week range
$1.37
$36
1% of range
Avg surprise (last 3)
-8.5%
Avg reaction (last 2)
-0.7%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-5.31 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-6.41 | $-5.60 | -14.5% | -46.0% | -1.4% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $-2.23 | $-2.09 | -6.7% | — | — | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-8.40 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-4.39 | $-4.21 | -4.3% | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-357.86 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1236.96 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-368.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-22.16 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-53.95 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $17.38 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-6M | $-7M | — | $-8M | $-6M | $-6M | — | $-5M |
| Net income | $-6M | $-7M | — | $-8M | $-6M | $-6M | — | $-5M |
| EPS (diluted) | $-5.31 | $-6.41 | — | $-2.23 | $-151.29 | $-1581.81 | — | $-357.86 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10M | $15M | $22M | $21M | $9M | $2M | $9M | $8M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $11M | $16M | $23M | $23M | $11M | $4M | $11M | $10M |
| Total assets | $15M | $20M | $27M | $27M | $16M | $8M | $16M | $15M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $8M | $8M | $10M | $10M | $9M | $10M | $11M | $11M |
| Total equity | $6M | $12M | $17M | $17M | $7M | $-1M | $5M | $4M |
Implied volatility — last 90 days
No IV snapshots yet for APVO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
APVO earnings FAQ
How does APVO stock usually react to earnings?
Across the last 2 reports the average next-day move was ±0.7%, up 0 times and down 2 times.